In patients with JDM, the anti-Mi2, anti-MDA-5, anti-NXP-2, and anti-TIF-1γ autoantibodies are the most common MSAs and are specific for dermatomyositis [2, 6]. Here, MORC3 is linked to juvenile dermatomyositis.